United Kingdom · Question · Written question
UIN 21813
Brain: Tumours
Introduced
28 August 2026
Last action
—
Status
Awaiting answer
Sponsors
—
Subjects
Discovery layer
Source updated
28 August 2026
Summary
To ask the Secretary of State for Health and Social Care, whether she will make representations to NuvationBio to encourage access to the SIGMA Phase 3 trial of Safusideniv for eligible patients at UK hospitals.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.